CBIS Financials 07/16/2014 17:15:27 Cannabis Scie
Post# of 306
Cannabis Science, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 83 37 74 4
Cost of Revenue - - - -
Gross Profit 83 37 74 4
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 3,328 5,442 8,390 8,163
Non-Recurring Items 9 456 - -
Other 111 59 22 27
Operating Income (3,365) (16,633) (8,338) (8,186)
Income From Continuing Operations
Add'l Income/Expense Items (2,568) 11,202 - 36
Earnings Before Interest and Tax (5,933) (16,028) (8,338) (8,151)
Interest Expense 1 9 1 3
Earnings Before Tax (5,934) (16,037) (8,339) (8,154)
Income Tax - 1 - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,934) (16,038) (8,339) (8,154)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,934) (16,038) (8,339) (8,154)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (5,934) (16,038) (8,339) (8,154)